Charles Schwab’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.41M Buy
195,455
+18,267
+10% +$225K ﹤0.01% 2610
2025
Q1
$1.09M Buy
177,188
+2,770
+2% +$17.1K ﹤0.01% 2811
2024
Q4
$1.41M Buy
174,418
+17,869
+11% +$145K ﹤0.01% 2791
2024
Q3
$1.26M Hold
156,549
﹤0.01% 2850
2024
Q2
$678K Buy
156,549
+12,132
+8% +$52.5K ﹤0.01% 3067
2024
Q1
$612K Sell
144,417
-6,877
-5% -$29.2K ﹤0.01% 2952
2023
Q4
$569K Buy
151,294
+8,040
+6% +$30.2K ﹤0.01% 3028
2023
Q3
$530K Buy
143,254
+18,651
+15% +$69K ﹤0.01% 3017
2023
Q2
$494K Buy
124,603
+101,999
+451% +$404K ﹤0.01% 3057
2023
Q1
$93.6K Buy
22,604
+8,656
+62% +$35.8K ﹤0.01% 3259
2022
Q4
$58.9K Hold
13,948
﹤0.01% 3328
2022
Q3
$40K Hold
13,948
﹤0.01% 3380
2022
Q2
$57K Sell
13,948
-84,742
-86% -$346K ﹤0.01% 3375
2022
Q1
$541K Buy
98,690
+4,401
+5% +$24.1K ﹤0.01% 3075
2021
Q4
$430K Hold
94,289
﹤0.01% 3190
2021
Q3
$439K Hold
94,289
﹤0.01% 3180
2021
Q2
$647K Buy
94,289
+11,711
+14% +$80.4K ﹤0.01% 3081
2021
Q1
$825K Buy
82,578
+1,997
+2% +$20K ﹤0.01% 2912
2020
Q4
$599K Buy
80,581
+10,823
+16% +$80.5K ﹤0.01% 2921
2020
Q3
$421K Buy
69,758
+6,806
+11% +$41.1K ﹤0.01% 2922
2020
Q2
$397K Buy
62,952
+3,060
+5% +$19.3K ﹤0.01% 2919
2020
Q1
$216K Hold
59,892
﹤0.01% 2992
2019
Q4
$437K Buy
59,892
+4,911
+9% +$35.8K ﹤0.01% 2870
2019
Q3
$351K Hold
54,981
﹤0.01% 2929
2019
Q2
$494K Buy
+54,981
New +$494K ﹤0.01% 2815
2019
Q1
Sell
-5,920
Closed -$39K 3193
2018
Q4
$39K Buy
+5,920
New +$39K ﹤0.01% 3134
2016
Q2
Sell
-9,075
Closed -$121K 3115
2016
Q1
$121K Hold
9,075
﹤0.01% 2968
2015
Q4
$93K Hold
9,075
﹤0.01% 3044
2015
Q3
$91K Hold
9,075
﹤0.01% 3042
2015
Q2
$177K Buy
+9,075
New +$177K ﹤0.01% 2996